Related Experiment Video
Updated: Jul 2, 2026

Germ Cell Transplantation and Testis Tissue Xenografting in Mice
Published on: February 6, 2012
Divergent biology and outcomes of somatic transformations in germ cell tumors
Zachariah Thomas1, Andrew C Johns1, Michael Glover1
1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Purpose:
Somatic-type malignancy (SM) of germ cell tumor (GCT) is rare but demonstrates aggressive behavior. Differences by primary site, time to transformation, and mutational status remain poorly characterized.
Patients And Methods:
We reviewed all SM patients between June 2016 and May 2025 at a tertiary referral center. Time to somatic transformation (TST) was defined from the initial GCT diagnosis to SM detection. SM were classified based on time of detection- at initial diagnosis (de novo), at consolidative surgery, at relapse within 5 years, and evolved SM at relapse after 5 years. Descriptive statistics, Kaplan-Meier estimates, and Cox regression analyses were used.
Results:
72 patients were identified: 40 (56%) with testicular, 24 (33%) with mediastinal, and 8 (11%) with other primaries. 22/24 (92%) mediastinal tumors with SM had sarcomatous transformation. Sarcoma was seen in 25/42 (60%) of de novo SM while adenocarcinoma was detected as an evolved entity in 5/6 (83.3%) cases. Embryonic type neuroectodermal tumor (ENET) histology carried poor prognosis compared to non-ENET histology (median, OS 1.8 vs 8 years; HR, 1.94; P = 0.1). Genomic data available showed PTEN-AKT-mTOR pathway mutations (33%) and TP53 mutations (33%), enriched in extra-gonadal sarcomatous SM.
Conclusions:
SM exhibits temporal, histologic, and molecular distinctions across primary sites. Response to frontline therapy and survival outcomes are poor. Future direction includes the exploration of underlying predictors of transformation and identification of targetable alterations in the relapsed setting.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Methods of Nuclear Reprogramming
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cellular Differentiation
A zygote is a...
Somatic to iPS Cell Reprogramming

